Pharmaceuticals [1]
Over the past decade, Novartis Pharmaceuticals Canada has introduced 20 new medicines that have had an important impact on patients suffering from a wide variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation and osteoporosis.
A [2]
Aclasta* (zoledronic acid injection)
Bone Metabolism Regulator
Important information for healthcare professionals (2010) [5]
Public Communication (2010) [6]
Important information for healthcare professionals (2005) [7]
Public Communication (2005) [8]
*Aclasta is a registered trademark
Afinitor* / Afinitor* DISPERZ** (everolimus tablets)
mTOR Kinase Inhibitor
Product Monograph [10]
*Afinitor is a registered trademark **DISPERZ is a trademark
Aimovig* (erenumab)
Anti-Calcitonin gene-related peptide receptor (anti-CGRPR)
Patient Medication Information (Autoinjector) [11]
Product Monograph [12]
*AIMOVIG is a trademark of Amgen Inc. used under license by Novartis Pharmaceuticals Canada Inc.
Alomide* (Lodoxamide)
Anti-allergy Agent
Consumer Information [13]
Product Monograph [14]
*Alomide is a trademark of Novartis
Argatroban* (argatroban)
Antithrombotic
Consumer Information [15]
Product Monograph [16]
*Argatroban is a Novartis product
Arzerra* (ofatumumab)
Antineoplastic Agent
Consumer Information [17]
Product Monograph [18]
Important information for healthcare professionals (August 2014) [19]
Important information for healthcare professionals (2014) [20]
Public Communication (August 2014) [21]
Public Communication (2014) [22]
*ARZERRA is a trademark
Atriance* (Nelarabine Injection)
Antineoplastic Agent
Consumer Information [23]
Product Monograph [24]
*ATRIANCE is a registered trademark
Azarga* (brinzolamide and timolol)
Topical Carbonic Anhydrase Inhibitor and Topical Beta-Adrenergic Blocking Agent
Consumer Information [25]
Product Monograph [26]
*Azarga is a Novartis product
Azopt* (Brinzolamide Ophthalmic Suspension)
Topical Carbonic Anhydrase Inhibitor
Consumer Information [27]
Product Monograph [28]
*Azopt is a trademark of Novartis
B [29]
Betoptic S* (Betaxolol Hydrochloride Ophthalmic Suspension)
Antiglaucoma Agent (Ophthalmic)
Consumer Information [30]
Product Monograph [31]
*a trademark of Novartis
C [32]
Ciloxan* (ciprofloxacin hydrochloride)
Antibacterial Agent
Product Monograph [33]
Patient Medication Information [34]
*Ciloxan is a trademark of Novartis
CiproDex* (Ciprofloxacin /Dexamethasone Otic Suspension)
Antibacterial - Corticosteroid (Otic)
Consumer Information [35]
Product Monograph [36]
*a trademark of Novartis
Comtan* (entacapone)
COMT-Inhibitor
Consumer Information [37]
Product Monograph [38]
*Comtan is a registered trademark
Cosentyx* (secukinumab)
Biological Response Modifier
Consumer Information [39]
Product Monograph [40]
*COSENTYX and SensoReady are registered trademarks
D [41]
Desferal* (deferoxamine mesylate for injection)
Iron and Aluminum Chelating Agent
Consumer Information [42]
Product Monograph [43]
*Desferal is a registered trademark
Diovan* (valsartan)
Angiotensin II AT1 Receptor Blocker
Consumer Information [44]
Product Monograph [45]
*Diovan is a registered trademark
Diovan*-HCT (valsartan and hydrochlorothiazide)
Angiotensin II AT1 Receptor Blocker and Diuretic
Consumer Information [46]
Product Monograph [47]
*Diovan is a registered trademark
DuoTrav PQ* (travoprost/timolol)
Prostaglandin F2a analogue and beta-adrenergic receptor blocker
Consumer Information [48]
Product Monograph [49]
*DuoTrav is a trademark of Novartis
Durezol* (difluprednate)
Topical Corticosteroid
Consumer Information [50]
Product Monograph [51]
*Durezol is a Novartis product
E [52]
Entresto* (sacubitril/valsartan)
Neutral endopeptidase inhibitor/Angiotensin II AT1 receptor blocker
Product Monograph [53]
Patient Medication Information [54]
*ENTRESTO is a trademark
Estalis* (norethindrone acetate and estradiol-17ß)
Progestin-Estrogen
Consumer Information [55]
Product Monograph [56]
*Estalis is a registered trademark
Estradot* (estradiol-17ß)
Estrogen
Consumer Information [57]
Product Monograph [58]
*Estradot is a registered trademark
Exelon* (rivastigmine hydrogen tartrate)
Cholinesterase Inhibitor
Consumer Information [59]
Product Monograph [60]
Important information for healthcare professionals (2001) [61]
*Exelon is a registered trademark
Exelon* Patch (rivastigmine transdermal patch)
Cholinesterase Inhibitor
Consumer Information [62]
Product Monograph [63]
Important information for healthcare professionals (2010) [64]
Public Communication (2010) [65]
*Exelon is a registered trademark
Exjade* (deferasirox)
Iron Chelating Agent
Consumer Information [66]
Product Monograph [67]
Important information for healthcare professionals (2009) [68]
Public Communication (2009) [69]
Important information for healthcare professionals (2008) [70]
Public Communication (2008) [71]
Important information for healthcare professionals (2007) [72]
Public Communication (2007) [73]
*Exjade is a registered trademark
Extavia* (Interferon beta-1b)
Immunomodulator
Consumer Information [74]
Product Monograph [75]
*Extavia is a registered trademark
F [76]
Famvir* (famciclovir)
Antiviral Agent
Consumer Information [77]
Product Monograph [78]
*Famvir is a registered trademark
Femara* (letrozole)
Non-steroidal aromatase inhibitor; Inhibitor of estrogen biosynthesis; Anti-tumour agent
Consumer Information [79]
Product Monograph [80]
Important information for healthcare professionals (2006) [81]
Important information for healthcare professionals (2005) [82]
Public Communication (2005) [83]
*Femara is a registered trademark
Flarex* (Fluorometholone Acetate)
Corticosteroid
Consumer Information [84]
Product Monograph [85]
*Flarex is a trademark of Novartis
Foradil* (formoterol fumarate)
Bronchodilator
Consumer Information [86]
Product Monograph [87]
Important information for healthcare professionals (2005) [88]
*Foradil is a registered trademark
G [89]
Gilenya* (fingolimod (as fingolimod hydrochloride))
Sphingosine 1-phosphate receptor modulator
Consumer Information [90]
Product Monograph [91]
Important information for healthcare professionals (2012) [92]
Public Communication (2012) [93]
www.gilenya.ca [94]
*Gilenya is a registered trademark
Gleevec* (imatinib mesylate)
Protein Kinase Inhibitor
Consumer Information [95]
Product Monograph [96]
Important information for healthcare professionals (2009) [97]
Fact Sheet (2009) [98]
Important information for healthcare professionals (2006) [99]
Public Communication (2006) [100]
Important information for healthcare professionals and patients (2016) [101]
*Gleevec is a registered trademark
H [102]
Hycamtin* (Topotecan hydrochloride for Injection)
Antineoplastic Agent
Consumer Information [103]
Product Monograph [104]
*HYCAMTIN is a registered trademark
I [105]
IZBA* (Travoprost ophthalmic solution)
Elevated Intraocular Pressure Therapy
Patient Medication Information [106]
Product Monograph [107]
*IZBA is a trademark of Novartis
Ilaris* (canakinumab)
Immunomodulator
Consumer Information [108]
Product Monograph [109]
*Ilaris is a registered trademark
Ilevro* (nepafenac)
Nonsteroidal Anti-Inflammatory
Product Monograph [110]
Consumer Information [111]
*Ilevro is a Novartis product
Iopidine* (apraclonidine)
Antiglaucoma Preparations and Miotics
Patient Medication Information [112]
Product Monograph [113]
*Iopidine is a trademark of Novartis
Isopto* Carpine (pilocarpine hydrochloride)
Parasympathomimetic
Consumer Information [114]
Product Monograph [115]
*Isopto is a trademark of Novartis
J [116]
Jadenu* (Deferasirox)
Iron Chelating Agent
Consumer Information [117]
Product Monograph [118]
Important information for healthcare professionals (2016) [119]
*Jadenu is a trademark
Jakavi* (ruxolitinib)
Antineoplastic Agent
Consumer Information [120]
Product Monograph [121]
*Jakavi is a registered trademark
K [122]
Kisqali* (ribociclib)
Protein Kinase Inhibitor
Patient Medication Information [123]
Product Monograph [124]
*Kisqali is a trademark
Kymriah* (Tisagenlecleucel)
Antineoplastic and immunomodulating agents
Patient Medication Information [125]
Product Monograph [126]
*KYMRIAH is a trademark
L [127]
Lamisil* (terbinafine hydrochloride)
Antifungal Agent
Consumer Information [128]
Product Monograph [129]
Important information for healthcare professionals (2001) [130]
*Lamisil is a registered trademark
Lescol* (discontinued) / Lescol* XL (fluvastatin sodium)
Lipid Metabolism Regulator
Consumer Information [131]
Product Monograph [132]
*Lescol is a registered trademark
Lioresal* (baclofen)
Antispastic Agent
Consumer Information [133]
Product Monograph [134]
*Lioresal is a registered trademark
Lioresal* Intrathecal (baclofen injection)
Antispastic Agent
Consumer Information [135]
Product Monograph [136]
*Lioresal is a registered trademark
Lopresor* / Lopresor SR* (metoprolol tartrate)
B - Adrenergic Receptor Blocking Agent
Consumer Information [137]
Product Monograph [138]
*Lopresor and Lopresor SR are registered trademarks
Lucentis* (ranibizumab injection)
Antineovascularisation agent
Consumer Information [139]
Product Monograph [140]
*Lucentis is a registered trademark
M [141]
Maxidex* (dexamethasone)
Corticosteroid
Consumer Information [142]
Prescribing Information [143]
*Maxidex is a trademark of Novartis
Maxitrol* (neomycin, polymyxin B sulfates and dexamethasone)
Anti-inflammatory/Antibiotic
Consumer Information [144]
Prescribing Information [145]
*Maxitrol is a trademark of Novartis
Mekinist* (Trametinib Tablets)
Protein Kinase Inhibitor
Consumer Information [146]
Product Monograph [147]
*MEKINIST is a registered trademark
Myfortic* (mycophenolic acid (as mycophenolate sodium))
Immunosuppressant
Consumer Information [148]
Product Monograph [149]
Important information for healthcare professionals (2009) [150]
Public Communication (2009) [151]
Important information for health care professionals (2016) [152]
*Myfortic is a registered trademark
N [153]
Neoral* (cyclosporine)
Immunosuppressant
Consumer Information [154]
Product Monograph [155]
Neoral* Oral Solution-Recall Notice Lot H5131-January 2013 [156]
Recall of Lot H5131-Return Process-January 2013 [157]
*Neoral is a registered trademark
Nevanac* (nepafenac)
Nonsteroidal Anti-Inflammatory
Consumer Information [158]
Product Monograph [159]
*a trademark of Novartis
O [160]
Onbrez* Breezhaler* (indacaterol maleate)
Long-acting beta2-agonist
Consumer Information [161]
Product Monograph [162]
*Onbrez and Breezhaler are registered trademarks
P [163]
Pataday* (Olopatadine Hydrochloride)
Anti-allergy Agent
Consumer Information [165]
Product Monograph [166]
*Pataday is a registered trademark of Novartis
Patanol* (Olopatadine Hydrochloride)
Anti-allergy Agent
Consumer Information [167]
Product Monograph [168]
*Patanol is a Registered trademark of
Pazeo* (olopatadine)
Anti-allergy Agent
Patient Medication Information [169]
Product Monograph [170]
*Pazeo is a trademark of Novartis
Phosphate-Novartis (discontinued) (Sodium acid phosphate)
Hypercalciuria, Electrolyte Replenisher
Patient Information [171]
Phosphate-Novartis - discontinued
Proleukin* (aldesleukin)
Biological Response Modifier
Product Monograph [172]
*Proleukin is a registered trademark
R [173]
Revolade* (Eltrombopag)
Thrombopoietin Receptor Agonist
Consumer Information [174]
Product Monograph [175]
Important information for healthcare professionals (2016) [176]
*REVOLADE is a registered trademark
Ritalin* (methylphenidate hydrochloride)
Central Nervous System Stimulant
Consumer Information [177]
Product Monograph [178]
Public Communication (2015) [179]
*Ritalin is a registered trademark
Rydapt* (midostaurine)
Antineoplastic Agent
Consumer Information [180]
Product Monograph [181]
*Rydapt is a trademark
S [182]
Sandimmune* I.V. (cyclosporine)
Immunosuppressant
Consumer Information [183]
Product Monograph [184]
*Sandimmune is a registered trademark
Sandostatin* / Sandostatin* LAR* (octreotide acetate injection) / (octreotide as acetate for injectable suspension)
Synthetic Octapeptide Analogue of Somatostatin
Consumer Information [185]
Product Monograph [186]
*Sandostatin and LAR are registered trademarks
Sebivo* (telbivudine)
Antiviral Agent
Consumer Information [187]
Product Monograph [188]
Important information for healthcare professionals (2008) [189]
Public Communication (2008) [190]
*Sebivo is a registered trademark
Seebri* Breezhaler* (glycopyrronium bromide)
Long-acting muscarinic antagonist
Consumer Information [191]
Product Monograph [192]
*Seebri and Breezhaler are registered trademarks
Signifor* (Pasireotide Injection)
Synthetic Pasireotide Analogue of Somatostatin
Consumer Information [193]
Product Monograph [194]
*Signifor is a registered trademark
Signifor* LAR* (Pasireotide)
Synthetic Pasireotide Analogue of Somatostatin
Consumer Information [195]
Product Monograph [196]
Signifor* and LAR* are registered trademarks
Simbrinza* (brinzolamide / brimonidine tartrate)
Topical Carbonic Anhydrase Inhibitor and Topical Alpha-2 Agonist Agent
Consumer Information [197]
Product Monograph [198]
*Simbrinza is a Novartis product
Simulect* (basiliximab)
Immunosuppressant
Consumer Information [199]
Product Monograph [200]
*Simulect is a registered trademark
Slow-K* (potassium chloride) (discontinued)
Potassium Supplement
Consumer Information [201]
*Slow-K is a registered trademark
Stalevo* (levodopa, carbidopa and entacapone)
Anti-parkinsonian Dopaminergic Agent
Consumer Information [202]
Product Monograph [203]
*Stalevo is a registered trademark
T [204]
TOBI* (tobramycin solution for inhalation)
Respiratory Antibiotic
Consumer Information [205]
Product Monograph [206]
*TOBI is a registered trademark
TOBI* Podhaler* (Tobramycin Inhalation Powder)
Respiratory Antibiotic
Consumer Information [207]
Product Monograph [208]
* TOBI and Podhaler are registered trademarks
Tafinlar* (Dabrafenib (as dabrafenib mesylate))
Protein Kinase Inhibitor
Consumer Information [209]
Product Monograph [210]
Important information for healthcare professionals (2015) [211]
*TAFINLAR is a registered trademark
Tasigna* (nilotinib)
Protein-tyrosine Kinase Inhibitor
Consumer Information [212]
Product Monograph [213]
Important information for healthcare professionals (2013) [214]
Public Communication (2013) [215]
Important information for healthcare professionals (2011) [216]
Fact sheet (2011) [217]
Important information for healthcare professionals (2010) [218]
Fact Sheet (2010) [219]
Important information for healthcare professionals and patients (2016) [101]
*Tasigna is a registered trademark
Tegretol* (carbamazepine)
Anticonvulsant, Antimanic, For Symptomatic Relief Of Trigeminal Neuralgia
Consumer Information [220]
Product Monograph [221]
Important information for healthcare professionals (2008) [222]
*Tegretol is a registered trademark
TobraDex* (Tobramycin and Dexamethasone)
Antibacterial and Corticosteroid
Patient Medication Information [223]
Product Monograph including Patient Medication Information [224]
*Tobradex is a trademark of Novartis
Tobrex* (Tobramycin)
Antibacterial (ophthalmic)
Product Monograph [225]
Patient Medication Information [226]
*Tobrex is a trademark of Novartis
Transderm-Nitro* (nitroglycerin)
Antianginal Agent
Consumer Information [227]
Product Monograph [228]
*Transderm-Nitro is a registered trademark
Travatan* Z (Travoprost)
Prostaglandin F2a analogue
Patient Medication Information [229]
Product Monograph including Patient Medication Information [230]
*Travatan is a trademark of Novartis
Triesence* (triamcinolone acetonide)
Visualization Agent
Consumer Information [231]
Product Monograph [232]
*Triesence is a trademark of Novartis
Trileptal* (oxcarbazepine)
Antiepileptic
Consumer Information [233]
Product Monograph [234]
Important information for healthcare professionals (2005) [235]
*Trileptal is a registered trademark
Tykerb* (lapatinib tablets (as lapatinib ditosylate))
Antineoplastic Agent
Consumer Information [236]
Product Monograph [237]
Important information for healthcare professionals [238]
Public Communication (2013) [239]
*TYKERB is a registered trademark
U [240]
Ultibro* Breezhaler* (indacaterol maleate and glycopyrronium bromide)
Long-acting beta2-agonist and Long-acting muscarinic antagonist
Consumer Information [241]
Product Monograph [242]
*Ultibro and Breezhaler are registered trademarks
V [243]
Vigamox* (Moxifloxacin Ophtalmic Solution)
Antibacterial (ophtalmic)
Consumer Information [244]
Product Monograph [245]
*a trademark of Novartis
Visudyne* (verteporfin for injection)
Photosensitizing Agent for Photodynamic Therapy of Choroidal Neovascularization
Consumer Information [246]
Product Monograph [247]
*Visudyne is a registered trademark
Voltaren Rapide* (diclofenac potassium)
Nonsteroidal Anti-Inflammatory Drug (NSAID)
Consumer Information [248]
Product Monograph [249]
Important information for healthcare professionals (2014) [250]
Public Communication (2014) [251]
*Voltaren Rapide is a registered trademark
Voltaren* / Voltaren* SR (diclofenac sodium)
Nonsteroidal Anti-Inflammatory Drug (NSAID)
Consumer Information [252]
Product Monograph [253]
Important information for healthcare professionals (2014) [254]
Public Communication (2014) [255]
*Voltaren is a registered trademark
Voltaren* Ophtha (Diclofenac Sodium)
Anti-inflammatory Analgesic Agent
Consumer Information [256]
Product Monograph [257]
*Voltaren is a trademark of Novartis
Votrient* (Pazopanib (as pazopanib hydrochloride))
Antineoplastic Agent
Consumer Information [258]
Product Monograph [259]
Important information for healthcare professionals (2013) [260]
Public Communication (2013) [261]
Video [262]
*VOTRIENT is a registered trademark
X [263]
Xolair* (omalizumab)
IgE-Neutralizing Antibody (Anti-IgE)
Consumer Information [264]
Product Monograph [265]
*Xolair is a registered trademark
Z [266]
Zofran* / Zofran* ODT ((ondansetron hydrochloride dihydrate))
Antiemetic
Consumer Information [267]
Product Monograph [268]
Important information for healthcare professionals (2014) [269]
Important information for healthcare professionals (2012) [270]
Public Communication (2012) [271]
*ZOFRAN is a registered trademark
Zometa* (zoledronic acid for injection)
Bone Metabolism Regulator
Consumer Information [272]
Product Monograph [273]
Important information for healthcare professionals (2005) [274]
Public Communication (2005) [275]
Important information for healthcare professionals (2004) [276]
*Zometa is a registered trademark
Zykadia * (Ceritinib)
Protein Kinase Inhibitor
Consumer Information [277]
Product Monograph [278]
Important information for healthcare professionals (2015) [279]
*ZYKADIA is a registered trademark